Advertisement
GERN vs IAC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GERN is a StrongBuy and IAC is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GERN’s FA Score shows that 0 FA rating(s) are green whileIAC’s FA Score has 0 green FA rating(s).
- GERN’s FA Score: 0 green, 5 red.
- IAC’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GERN’s TA Score shows that 7 TA indicator(s) are bullish while IAC’s TA Score has 3 bullish TA indicator(s).
- GERN’s TA Score: 7 bullish, 3 bearish.
- IAC’s TA Score: 3 bullish, 7 bearish.
Price Growth
GERN (@Biotechnology) experienced а -4.32% price change this week, while IAC (@Internet Software/Services) price change was -0.64% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -2.02%. For the same industry, the average monthly price growth was +10.36%, and the average quarterly price growth was +8.87%.
The average weekly price growth across all stocks in the @Internet Software/Services industry was -0.29%. For the same industry, the average monthly price growth was +2.40%, and the average quarterly price growth was +19.37%.
Reported Earning Dates
GERN is expected to report earnings on Aug 07, 2025.
IAC is expected to report earnings on Aug 12, 2025.
Industries' Descriptions
@Biotechnology (-2.02% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Internet Software/Services (-0.29% weekly)Companies in this industry typically license software on a subscription basis and it is centrally hosted. Such products usually go by the names web-based software, on-demand software and hosted software. Cloud computing has emerged as a major force in this space, making it possible to save files to a remote database (without requiring them to be saved on local storage device); as long as a device has access to the web, it can access the data and the software programs to run it. This has in many cases facilitated cost efficiency, speed and security of data for businesses and consumers. Alphabet Inc., Facebook, Inc. and Yahoo! Inc. are some well-known names in the internet software/services industry.
| GERN | IAC | GERN / IAC | |
| Capitalization | 987M | 4.59B | 21% |
| EBITDA | -114.49M | 996M | -11% |
| Gain YTD | -56.215 | 0.601 | -9,356% |
| P/E Ratio | N/A | 17.99 | - |
| Revenue | 116M | 4.37B | 3% |
| Total Cash | 397M | 1.45B | 27% |
| Total Debt | 122M | 2.02B | 6% |
GERN | IAC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 51 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 93 | |
PRICE GROWTH RATING 1..100 | 63 | 75 | |
P/E GROWTH RATING 1..100 | 74 | 76 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IAC's Valuation (51) in the Internet Software Or Services industry is somewhat better than the same rating for GERN (92) in the Biotechnology industry. This means that IAC’s stock grew somewhat faster than GERN’s over the last 12 months.
IAC's Profit vs Risk Rating (100) in the Internet Software Or Services industry is in the same range as GERN (100) in the Biotechnology industry. This means that IAC’s stock grew similarly to GERN’s over the last 12 months.
IAC's SMR Rating (93) in the Internet Software Or Services industry is in the same range as GERN (97) in the Biotechnology industry. This means that IAC’s stock grew similarly to GERN’s over the last 12 months.
GERN's Price Growth Rating (63) in the Biotechnology industry is in the same range as IAC (75) in the Internet Software Or Services industry. This means that GERN’s stock grew similarly to IAC’s over the last 12 months.
GERN's P/E Growth Rating (74) in the Biotechnology industry is in the same range as IAC (76) in the Internet Software Or Services industry. This means that GERN’s stock grew similarly to IAC’s over the last 12 months.
| GERN | IAC | |
|---|---|---|
| RSI ODDS (%) | 5 days ago 78% | 4 days ago 77% |
| Stochastic ODDS (%) | 4 days ago 86% | 4 days ago 78% |
| Momentum ODDS (%) | 4 days ago 85% | 4 days ago 80% |
| MACD ODDS (%) | 4 days ago 77% | 4 days ago 71% |
| TrendWeek ODDS (%) | 4 days ago 82% | 4 days ago 74% |
| TrendMonth ODDS (%) | 4 days ago 78% | 4 days ago 77% |
| Advances ODDS (%) | 8 days ago 74% | 6 days ago 68% |
| Declines ODDS (%) | 6 days ago 77% | 4 days ago 74% |
| BollingerBands ODDS (%) | 7 days ago 80% | 5 days ago 63% |
| Aroon ODDS (%) | 4 days ago 77% | 4 days ago 64% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EMTY | 13.09 | 0.27 | +2.13% |
| ProShares Decline of the Retl Store ETF | |||
| FEMB | 28.36 | -0.11 | -0.39% |
| First Trust Emerging Mkts Lcl Ccy Bd ETF | |||
| PYZ | 91.34 | -0.55 | -0.60% |
| Invesco DW Basic Materials Momt ETF | |||
| QDF | 71.05 | -0.91 | -1.26% |
| FlexShares Quality Dividend ETF | |||
| FNGS | 61.02 | -1.08 | -1.74% |
| MicroSectors™ FANG+™ ETN | |||